Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
Leman Biotech has raised $28.8M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Leman Biotech's investors include Mony Valley, Mining World Star, XtalPi, Tiantu Capital, Fuho Capital.
Leman Biotech is headquartered in Lausanne, Switzerland.
Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
Leman Biotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leman Biotech — Funding & Investors." VCBacked, January 26, 2026, https://www.vcbacked.co/company/leman-biotech. Accessed August 15, 2026.
VCBacked. (2026). Leman Biotech — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/leman-biotech
{{cite web |title=Leman Biotech — Funding & Investors |url=https://www.vcbacked.co/company/leman-biotech |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated